Using a multi-infusion strategy to reduce infections in premature infants

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the impact of a multi-infusion strategy on the rate of central line-associated bloodstream infections (CLABSI) in premature infants. The approach involves using specialized infusion devices designed to minimize the risk of microbial contamination while administering multiple intravenous medications and nutrition. The study aims to assess whether this strategy can reduce the incidence of infections and the need for antibiotics in this vulnerable population. Infants who meet specific eligibility criteria will be monitored for infection rates during their hospitalization.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Gestational age at birth ≤ 32 weeks
* Birthweight ≤ 1600 g
* Admitted in the first 3 days of life in the neonatal unit
* Hospitalized in the neonatal unit for at least 1 day
* Survived the first three days of life
* Requires the use of infusion sets for the administration of multiple drugs or solutions, whether or not they have the device in place
* Receipt of the non-opposition from parents or guardians

Exclusion Criteria:

* Opposition by parents or guardians
* Lethal or complicated malformation
* Chromosomal anomaly
* Participation of the infant in any other research that may interfere with the results of this study, in the judgment of the investigator

Where it's running

• Service de néonatologie Hôpital Femme Mère Enfant
  Bron, France Recruiting
• Service Pédiatrie néonatale et réanimations CHU Montpellier
  Montpellier, France Not yet recruiting
• Service de néonatologie CHU de Strasbourg
  Strasbourg, France Active not recruiting

Study contacts

• Study coordinator: Jean-Charles PICAUD, MD, PhD
• Email: jean-charles.picaud@chu-lyon.fr
• Phone: 04 72 00 15 50

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biomarkers linked to congenital CMV using newborn blood spots

  Researchers will test protein and RNA markers in dried blood spots from newborns to see if they can identify congenital CMV sequelae early.

  Recruiting at 2 sites Copenhagen University Hospital, Rigshospitalet · Copenhagen and 1 other locations · NCT07635368

• Zinc supplementation for infants with severe infections in Tanzania

  This study is testing if giving zinc to young infants in Tanzania who are hospitalized with serious infections can help them recover better and live longer.

  Recruiting Phase 3 Harvard School of Public Health (HSPH) · Dar es Salaam · NCT06102044

• Database for tracking neonatal infections

  This study is creating a system to track and understand bacterial infections in newborns in the UK to help doctors respond quickly and improve care.

  Recruiting St George's, University of London · London · NCT05742490

• Measuring oxygen extraction in newborns with and without infections

  This study is trying to see if measuring oxygen levels in the blood can show differences between newborns with infections and those without, to help understand their breathing problems better.

  Recruiting Medical University of Graz · Graz, Styria · NCT04818762

• National survey on bacterial meningitis in children

  This study is trying to learn more about bacterial meningitis in children by looking at which bacteria are causing it and how things have changed since the introduction of vaccines.

  Recruiting Association Clinique Thérapeutique Infantile du val de Marne · Créteil · NCT04664569

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.